Ledger.Open graph →
SEC Form D · filed May 2, 2022

Facible BioDiagnostics, Inc

Offering
$2.8M
Sold
$2.8M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
MERIDIAN, ID
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (21)

Dan Geraci · Tucson, AZDirectorTravis M. Heriaud · Scottsdale, AZDirectorSteven Burden · MERIDIAN, IDExec · DirectorAlexander A. Wong · Denver, COExecShawn Bradley · Ottawa, Ontario, CanadaExecPatrik Burnas · Stockholm, V7DirectorCasi Wyatt · MERIDIAN, IDDirectorMark Tayles · Ottawa, Ontario, CanadaDirectorDouglas Margerum · Bethesda, MDExecHanna C. Shuvalova · Chicago, ILExecKenneth Bradley · Ottawa, Ontario, CanadaExecJosh G. Israel · Boston, MAExec · DirectorBrent Fawson · MERIDIAN, IDExecEric Hayden · MERIDIAN, IDDirectorDanna M. Murphy · Scottsdale, AZExec · DirectorMicah Kormylo · MERIDIAN, IDExecMatthew Hawkins · MERIDIAN, IDDirectorMark G. Currie · CAMBRIDGE, MAExecShaker J. Sadasivam · CAMBRIDGE, MADirectorClementine Gibard Bohachek · MERIDIAN, IDExecStephen Margerum · Bethesda, MDDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗